S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ANIX Anixa Biosciences Inc

2.99

-0.10 (-3.24%)

After Hours

Last Updated: 15:05:59

Delayed by 15 minutes

Anixa Bio says its COVID-19 compounds are expected to be effective against Omicron variant

To read the full story on Seeking Alpha, click here.

Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Anixa Biosciences Charts.

Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Anixa Biosciences Charts.

Anixa Biosciences Inc News

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
Tuesday 30 April 2024 (2 days ago) • PR Newswire (US)

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Thursday 18 April 2024 (2 weeks ago) • PR Newswire (US)

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Thursday 14 March 2024 (2 months ago) • PR Newswire (US)

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Monday 11 March 2024 (2 months ago) • PR Newswire (US)

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
Monday 12 February 2024 (3 months ago) • PR Newswire (US)

Form DEF 14A - Other definitive proxy statements
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
Monday 29 January 2024 (3 months ago) • PR Newswire (US)

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Tuesday 23 January 2024 (3 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 16 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 16 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 16 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 16 January 2024 (4 months ago) • Edgar (US Regulatory)

More Anixa Biosciences Inc News Articles

Verb Technology

Atacama Resources (PK)

BlackStar Enterprise (PK)

MicroCloud Hologram

Globestar Therapeutics (PK)

International Star (PK)

Seven Arts Entertainment (PK)

Mullen Automotive

Buildablock (PK)

Brookmount Explorations (PK)

FBEC Worldwide (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions